首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Anticancer research

缩写:ANTICANCER RES

ISSN:0250-7005

e-ISSN:1791-7530

IF/分区:1.7/Q4

文章目录 更多期刊信息

共收录本刊相关文章索引12855
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Yohei Asano,Norio Yamamoto,Katsuhiro Hayashi et al. Yohei Asano et al.
Background/aim: This study aimed to investigate the structure and functions of the membrane formed around liquid nitrogen-treated bones in the osteogenesis and revitalization of frozen bone using a rat model. ...
Ikuma Shioi,Hiroomi Ogawa,Ryozan Naito et al. Ikuma Shioi et al.
Background/aim: Adjuvant capecitabine and oxaliplatin (CAPOX) therapy is standard strategy for colorectal cancer with risk of recurrence. Early dose reduction (EDR) of CAPOX therapy is commonly used in real-world practice...
Kensuke Mitsunari,Hajime Fukushima,Hiroki Kurata et al. Kensuke Mitsunari et al.
Background/aim: The primary objective of this study was to identify predictors for biochemical recurrence (BCR) within 2 years following robot-assisted radical prostatectomy (RARP). Identifying predictors will enable insi...
Oksana Zemskova,Nathan Y Yu,Jan Leppert et al. Oksana Zemskova et al.
Background/aim: Many patients with glioblastoma experience an intracerebral recurrence and require a personalized treatment. This study aimed to facilitate this approach by identifying prognostic factors for progression-f...
Shohei Komatsu,Yoshihiko Yano,Takuya Mimura et al. Shohei Komatsu et al.
Background/aim: Sorafenib and lenvatinib have long been used as a first-line treatment for advanced hepatocellular carcinoma (HCC). Along with the development of systemic chemotherapy for HCC, the concept of conversion he...
Yuki Uemichi,Miyuki Mabuchi,Natsumi Tsuchiya et al. Yuki Uemichi et al.
Background/aim: Glioblastoma is an incurable cancer with limited treatment options and a low survival rate. Temozolomide is the standard marketed small-molecule agent for glioblastoma therapy; therefore, we aimed to find ...
Yutaka Yamamoto,Mituhisa Nishimoto,Yasunori Akashi et al. Yutaka Yamamoto et al.
Background/aim: The therapeutic landscape for metastatic castration-resistant prostate cancer (mCRPC) has changed dramatically with the introduction of several novel agents. However, limited data are available to determin...
Takayuki Ohguri,Takahiro Morisaki,Hirohide Itamura et al. Takayuki Ohguri et al.
Background/aim: To evaluate the association between prophylactic administration of clarithromycin (CAM) and the development of radiation pneumonitis (RP) in patients treated with intensity modulated radiation therapy (IMR...
Soji Toda,Nao Saito,Mei Kadoya et al. Soji Toda et al.
Background/aim: BRAF and TERT promoter mutations are associated with the poor prognosis of papillary thyroid carcinoma. This single-center retrospective study investigated the influence of these genes on advanced cases. ...
Eun-Young Choi,Eun-Ji Han,Su-Ji Jeon et al. Eun-Young Choi et al.
Background/aim: Kaempferol, a natural flavonoid, occurs abundantly in fruits and vegetables. It has various bioactivities, with antioxidant, anti-inflammatory, and other beneficial properties. The aim of this study was to...